Missteps in "tango" for epigenome targeting

Keith D. Robertson, Kapil N. Bhalla

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In this issue of Blood, Fandy and colleagues describe the results of a trial in which leukemia patients were treated with 5-azacytidine (5-azaC) and the HDAC inhibitor, entinostat. 1 Their results confirm the therapeutic efficacy of these agents but also demonstrate that we have much to learn about the mechanism of action of agents that target the epigenome.

Original languageEnglish (US)
Pages (from-to)2569-2570
Number of pages2
JournalBlood
Volume114
Issue number13
DOIs
StatePublished - Nov 19 2009

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Missteps in "tango" for epigenome targeting'. Together they form a unique fingerprint.

Cite this